Description
Specifications
| Form | Nasal spray formulation |
| Contents | 10 mg |
| Class | Terminally modified Semax (ACTH(4-10)) analog |
| Made in | USA |
| Testing | Third-party identity and purity, every lot |
| ADAMAX | C₅₀H₆₉N₁₁O₁₁S · MW 1032.2 · CAS not assigned |
How Is ADAMAX Studied?
ADAMAX is a synthetic analog of Semax, the ACTH(4-10)-derived heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), with an acetylated N-terminus and an adamantane-modified C-terminus. It is a newer research compound with little published literature of its own, so current interest builds on the larger body of Semax research, which has examined BDNF expression and TrkB signaling in rodent models. Researchers use ADAMAX to study how terminal modifications affect the stability and receptor activity of Semax-type peptides, and intranasal formulations support preclinical work on nose-to-brain delivery.
Storage
Store refrigerated at 2–8 °C, upright and capped, away from light.
FAQ
Do you carry Semax itself?
Yes. See the Selank / Semax nasal spray, the Selank / Semax blend vial and N-Acetyl Semax.
Is a Certificate of Analysis available?
Yes. Every lot is third-party tested, and the current lot’s COA is posted on this page.
Do you provide use or dosing guidance?
No. This product is sold strictly for laboratory research, and orders indicating human or animal use are cancelled.
For laboratory research use only. Not for human consumption.
